[Use-risk consideration in antibacterial chemotherapy].
Wuermeling
H B
HB
Institut für Rechtsmedizin, Universität Erlangen-Nürnberg, Germany.
D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005858:Germany; D006381:Helsinki Declaration; D006805:Human Experimentation; D006801:Humans; D007880:Legislation, Drug
D000890:Anti-Infective Agents